Taken together with the group comparison reported in Section 3.2, this suggests that having the apoE4 protein, as indicated by specific binding (apoE4 protein level ≥ 30,000 pg/mL), is a risk factor for cognitive impairment. The gene discussed is APOE; the disease is Cognitive impairment.